Moreover, RSL3 treatment resulted in lipid ROS accumulation and proliferation inhibition in xenograft tumors, as indicated by the elevated 4‐HNE and decreased Ki67 levels in xenograft tumor tissues. Here, MKI67 is linked to neoplasm.